Madrigal Pharmaceuticals (NASDAQ:MDGL) Lifted to Sell at StockNews.com
StockNews.com upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) to a sell rating in a report released on Tuesday morning. Other research analysts have also recently issued research reports about the stock. JMP Securities restated a market outperform rating and set a $383.00 price objective on shares of Madrigal Pharmaceuticals in a report on […]
More Stories
Mirador Capital Partners LP Sells 456 Shares of Airbnb, Inc. (NASDAQ:ABNB)
Mirador Capital Partners LP cut its holdings in shares of Airbnb, Inc. (NASDAQ:ABNB – Free Report) by 10.0% during the...
SPDR Portfolio Emerging Markets ETF (NYSEARCA:SPEM) Shares Sold by Financial Enhancement Group LLC
Financial Enhancement Group LLC trimmed its stake in shares of SPDR Portfolio Emerging Markets ETF (NYSEARCA:SPEM – Free Report) by...
Insteel Industries (NASDAQ:IIIN) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS
Insteel Industries (NASDAQ:IIIN – Get Free Report) released its quarterly earnings data on Thursday. The industrial products company reported $0.06...
LuxUrban Hotels (NASDAQ:LUXH) Faces Delisting from Nasdaq
LuxUrban Hotels Inc., a Delaware-based hotel company, recently received notice from The Nasdaq Stock Market LLC (Nasdaq) indicating that the...
BigBear.ai Holdings, Inc. Updates Pro Forma Financial InformationBigBear.ai Holdings, Inc. (Exact name of registrant as specified in its charter) made a recent filing with the United States Securities and Exchange Commission to provide an update on c
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Beech Hill Advisors Inc. Cuts Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Beech Hill Advisors Inc. reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.4% during the fourth...